Clinical trial
A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients…
NCT00351832 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00351832 |
|---|---|
| Title | A Study To Compare the Effect of Vildagliptin Compared to Placebo in Patients With Type 2 Diabetes |
| Official title | A Multicenter, Double-Blind, Randomized, Parallel-Group Study to Compare the Effect of 12 Weeks Treatment With Vildagliptin (50mg qd, 50mg Bid, 100mg qd) to Placebo in Patients With Type 2 Diabetes |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Vildagliptin |
| Enrollment | 236 |
| Start date | Jun 1, 2006 |
| First posted | Jul 13, 2006 |
| Last update posted | May 9, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: